Renal epithelioïd angiomyolipoma;Angiomyolipome épithélioïde rénal

Progres en Urologie

Volumn 19, Issue 7, 2009, Pages 457-461

  Lopater, J ^a   Daniel, L ^b   Akiki, A ^a   Boissier, R ^a   Lechevallier, É ^a   Coulange, C ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Epithelio d angiomyolipoma; Kidney; mTOR; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE; RAPAMYCIN; TUMOR MARKER;

ANGIOMYOLIPOMA; ENZYMOLOGY; HUMAN; KIDNEY TUMOR; METABOLISM; METHODOLOGY; NEPHRECTOMY; PATHOPHYSIOLOGY; PROGNOSIS; SHORT SURVEY; TREATMENT OUTCOME;

ANGIOMYOLIPOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOXORUBICIN; HUMANS; KIDNEY NEOPLASMS; NEPHRECTOMY; PROGNOSIS; PROTEIN KINASES; SIROLIMUS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 67649782442     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.purol.2009.01.010     Document Type: Short Survey

References (10)

1. Kenerson H., Folpe A.L., Takayama T.K., and Yeung R.S. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Hum Pathol 38 (2007) 1361-1371
2. Lane B.R., Aydin H., Danforth T.L., Zhou M., Remer E.M., Novick A.C., et al. Clinical correlates of renal angiomyolipoma subtypes in 209 patients: classic, fat poor, tuberous sclerosis associated and epithelioid. J Urol 180 (2008) 836-843
3. Folpe A.L., Mentzel T., Lehr H.A., Fisher C., Balzer B.L., and Weiss S.W. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol 29 (2005) 1558-1575
4. Amin M.B. Epithelioid angiomyolipoma. In: Flectcher C.D.M. (Ed). World Health Organization classification of tumour: pathology and genetics of tumours of the urinary system and male genital organs (2004), IARC Press, Lyon, France 68-69
5. Martignoni G., Pea M., Reghellin D., Zamboni G., and Bonetti F. PEComas: the past, the present and the future. Virchows Arch 452 (2008) 119-132
6. Bissler J.J., McCormack F.X., Young L.R., Elwing J.M., Chuck G., Leonard J.M., et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358 (2008) 140-151
7. Spie R., Devevey J.M., Ponnelle T., and Michel F. Angiomyolipoma with epithelioid contingent mimicking renal cell carcinoma. Prog Urol 15 (2005) 322-325
8. Lai H.Y., Chen C.K., Lee Y.H., Tsai P.P., Chen J.H., and Shen W.C. Multicentric aggressive angiomyolipomas: a rare form of PEComas. AJR Am J Roentgenol 186 (2006) 837-840
9. Park H.K., Zhang S., Wong M.K., and Kim H.L. Clinical presentation of epithelioid angiomyolipoma. Int J Urol 14 (2007) 21-22
10. Cornu J.N., Rouprêt M., Lang H., Long J.A., Neuzillet Y., Patard J.J., et al. Kidney cancer management in 2007: news and recommendations. Prog Urol 18 (2008) S81-S87